Patient Presentation

Patient’s Changing Condition Multiple Considerations To Balance

VALIANT High Early Risk of SCA

Implications of β-Blocker Underuse Prior To Device Implantation

DINAMIT Trial – 40-Day Wait

HAT - Home Use of Automated External Defibrillators for Sudden Cardiac Arrest

Wearable Cardioverter Defibrillator

Adherence to WCD Use

WCD Bridging the Waiting Period

Cleveland Clinic Post-PCI Registry WCD Use in Post-PCI Low EF Patients Associated With Improved Survival

Case

Patients With Low EF Following CABG SCA Risk During Recovery

Patients With Low EF Following CABG WCD Associated with Reduced Total Mortality

Case

MERIT-HF Mechanism of Death in Heart Failure

Medical Therapy Optimization Required Prior to Managing Long-Term Arrhythmic Risk

Other Indications Where WCD Might Be of Use?

Care Team Model

Heart Rhythm Society Sudden Cardiac Death Primary Prevention Protocols

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)